At a glance
The Clinical Laboratory Improvement Advisory Committee (CLIAC) provides guidance to the Department of Health and Human Services (HHS). The advice and guidance CLIAC provides to HHS pertains to general issues related to improvement in clinical laboratory quality and laboratory medicine practice.
About
The Clinical Laboratory Improvement Advisory Committee (CLIAC) is managed by the Centers for Disease Control and Prevention (CDC). CLIAC provides scientific and technical advice to the Department of Health and Human Services (HHS).
Impact
CLIAC advises HHS on improving clinical laboratory quality and laboratory medicine practice. The Committee also offers guidance on revising Clinical Laboratory Improvement Amendments (CLIA) standards.
Meetings
The next CLIAC meeting is November 6-7, 2024. Visit the Upcoming CLIAC Meeting page for more information.
Future Meetings
- April 9-10, 2025 (Atlanta, GA)
- November 5-6, 2025 (Virtual)
- April 8-9, 2026 (Atlanta, GA)
- November 4-5, 2026 (Virtual)
Past Meetings
Visit the CLIAC Meeting page to access resources from past meetings.
Members
The Committee has a consumer representative and has diverse membership across:
- Laboratory specialties.
- Professional roles: laboratory management, technical, physicians, nurses.
- Practice settings: academic, clinical, public health.
The clinical and anatomic pathology laboratory specialties represented include:
- Microbiology
- Immunology
- Chemistry
- Hematology
- Immunohematology
- Cytopathology
- Histopathology
- Genetic testing
- Informatics
The Committee also includes three ex officio members from the federal agencies that oversee the CLIA program, specifically the:
A nonvoting liaison representing the laboratory industry participates on the Committee.
Who to contact
Centers for Disease Control and Prevention (CDC)
Office of Laboratory Systems and Response (OLSR)
Division of Laboratory Systems (DLS)
1600 Clifton Road
Mailstop V24-3
Atlanta, GA 30329-4018
USA
Email: CLIAC@cdc.gov